Urinalysis Market to Surpass Market Valuation of USD 8.97 Billion by 2031
Westford, USA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Urinalysis Market will reach a value of USD 8.97 Billion by 2031, with a CAGR of 9.70%…
HomesToLife Ltd Announces Pricing of Initial Public Offering
SINGAPORE, Sept. 30, 2024 (GLOBE NEWSWIRE) -- HomesToLife Ltd. (“HTLM” or the “Company”) today announced the pricing of its initial public offering of an aggregate of 1,250,000 ordinary shares (the…
Form 8.3 – Learning Technologies Group plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION…
Prairie Provident Announces Closing of Initial $10 Million Subscription under Rights Offering
CALGARY, Alberta, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) is pleased to announce the closing of the initial $10.0 million subscription…
Titan Reports Voting Results from 2023 Annual General and Special Meeting
TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announced the voting results from its Annual General and Special Meeting of Shareholders (the…
Woodbridge International Closes Sale of All Bright Electric to Kiely Family of Companies
NEW HAVEN, Conn., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Woodbridge International, a global mergers and acquisitions firm, is pleased to announce the acquisition of its client, All Bright Electric by…
Woodbridge International Closes Sale of Cercone Exterior Restoration to The Valcourt Group
NEW HAVEN, Conn., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Woodbridge International, a global mergers and acquisitions firm, is pleased to announce the acquisition of its client, Cercone Exterior Restoration by…
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer,…
Eurobio Scientific : COMMUNIQUÉ DU 30 SEPTEMBRE 2024 EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE EUROBIO SCIENTIFIC S.A. INITIÉE PAR LA SOCIÉTÉ EB DEVELOPMENT
COMMUNIQUÉ DU 30 SEPTEMBRE 2024 RELATIF AU DÉPÔT DU PROJET DE NOTE D’INFORMATION ÉTABLI PAR LA SOCIÉTÉ Eurobio Scientific EN RÉPONSE AU PROJET D’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE…
EB DEVELOPMENT : COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ EUROBIO SCIENTIFIC
COMMUNIQUÉ DE PRESSE DU 30 SEPTEMBRE 2024 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS DE LA SOCIÉTÉ Eurobio Scientific INITIÉE PAR EB DEVELOPMENT AGISSANT DE CONCERT AVEC…